{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:10:56Z","timestamp":1786997456925,"version":"build-2736575974"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.thromres.2025.109321","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T02:03:30Z","timestamp":1745201010000},"page":"109321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Disseminated Intravascular Coagulopathy and Persistent Inflammation, Immunosuppression, and Catabolism Syndrome: Pathophysiology, shared pathways, and clinical implications"],"prefix":"10.1016","volume":"250","author":[{"given":"Nicole Ann","family":"Gunn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukei","family":"Oo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy Whei Lynn","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichole Yue Ting","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan Zhi","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Sherng Young","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2025.109321_bb0005","author":"RA C, SM N."},{"issue":"9","key":"10.1016\/j.thromres.2025.109321_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ. Res."},{"issue":"6","key":"10.1016\/j.thromres.2025.109321_bb0015","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0b013e318256e000","article-title":"Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care","volume":"72","author":"Gentile","year":"2012","journal-title":"J. Trauma Acute Care Surg."},{"issue":"2","key":"10.1016\/j.thromres.2025.109321_bb0020","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000002074","article-title":"Sepsis pathophysiology, chronic critical illness, and persistent inflammation-immunosuppression and catabolism syndrome","volume":"45","author":"Mira","year":"2017","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.thromres.2025.109321_bb0025","first-page":"9","article-title":"Innate immunity in the persistent inflammation, immunosuppression, and catabolism syndrome and its implications for therapy","author":"Horiguchi","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2025.109321_bb0030","article-title":"Consumptive coagulopathy is associated with organ dysfunction during PICS","author":"Winer","year":"2019","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"issue":"8","key":"10.1016\/j.thromres.2025.109321_bb0035","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9082662","article-title":"Disseminated Intravascular Coagulopathy is associated with the outcome of Persistent Inflammation, Immunosuppression and Catabolism Syndrome","volume":"9","author":"Nakamura","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.thromres.2025.109321_bb0040","first-page":"9","article-title":"Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome","author":"Hawkins","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109321_bb0045","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0b013e3182aafe6b","article-title":"Persistent inflammation-immunosuppression catabolism syndrome, a common manifestation of patients with enterocutaneous fistula in intensive care unit","volume":"76","author":"Hu","year":"2014","journal-title":"J. Trauma Acute Care Surg."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9010191","article-title":"Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) after Polytrauma: a rare syndrome with major consequences","volume":"9","author":"Hesselink","year":"2020","journal-title":"J. Clin. Med."},{"issue":"19","key":"10.1016\/j.thromres.2025.109321_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11195790","article-title":"Clinical criteria for persistent inflammation, immunosuppression, and catabolism syndrome: an exploratory analysis of optimal cut-off values for biomarkers","volume":"11","author":"Nakamura","year":"2022","journal-title":"J. Clin. Med."},{"issue":"14","key":"10.1016\/j.thromres.2025.109321_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25147770","article-title":"From molecular mechanisms to clinical therapy: understanding sepsis-induced multiple organ dysfunction","volume":"25","author":"Srdi\u0107","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.thromres.2025.109321_bb0065","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2843","article-title":"The pulmonary endothelial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis","volume":"18","author":"Schmidt","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.thromres.2025.109321_bb0070","first-page":"129","article-title":"The ratio of plasma angiopoietin-2 to angiopoietin-1 as a prognostic biomarker in patients with sepsis","author":"Seol","year":"2020","journal-title":"Cytokine"},{"issue":"12","key":"10.1016\/j.thromres.2025.109321_bb0075","doi-asserted-by":"crossref","DOI":"10.2337\/diacare.27.12.2918","article-title":"Plasma vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in diabetes: implications for cardiovascular risk and effects of multifactorial intervention","volume":"27","author":"Lim","year":"2004","journal-title":"Diabetes Care"},{"issue":"17","key":"10.1016\/j.thromres.2025.109321_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/S0021-9258(18)34015-8","article-title":"The acute phase response of plasma protein synthesis during experimental inflammation","volume":"257","author":"Schreiber","year":"1982","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.thromres.2025.109321_bb0085","doi-asserted-by":"crossref","DOI":"10.1097\/00000658-199802000-00015","article-title":"Albumin synthesis rates are not decreased in hypoalbuminemic cachectic cancer patients with an ongoing acute-phase protein response","volume":"227","author":"Fearon","year":"1998","journal-title":"Ann. Surg."},{"issue":"8432","key":"10.1016\/j.thromres.2025.109321_bb0090","article-title":"Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury","volume":"1","author":"Fleck","year":"1985","journal-title":"Lancet (Lond., Engl.)"},{"issue":"2","key":"10.1016\/j.thromres.2025.109321_bb0095","article-title":"Plasma antithrombin levels correlate with albumin and total protein in gestational hypertension and preeclampsia","volume":"4","author":"Ogawa","year":"2014","journal-title":"Pregn. Hypertens."},{"issue":"114","key":"10.1016\/j.thromres.2025.109321_bb0100","article-title":"Serum antithrombin III level is well correlated with multiple indicators for assessment of liver function and diagnostic accuracy for predicting postoperative liver failure in hepatocellular carcinoma patients","volume":"59","author":"Mizuguchi","year":"2012","journal-title":"Hepato-gastroenterology"},{"issue":"11","key":"10.1016\/j.thromres.2025.109321_bb0105","doi-asserted-by":"crossref","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109321_bb0110","doi-asserted-by":"crossref","DOI":"10.1046\/j.1538-7836.2003.00267.x","article-title":"Signaling events underlying thrombus formation","volume":"1","author":"Jackson","year":"2003","journal-title":"J. Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.thromres.2025.109321_bb0115","doi-asserted-by":"crossref","DOI":"10.1093\/clinchem\/46.8.1260","article-title":"Coagulation and bleeding disorders: review and update","volume":"46","author":"Triplett","year":"2000","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.thromres.2025.109321_bb0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2016.2252","article-title":"Association between serum calcium level and extent of bleeding in patients with intracerebral hemorrhage","volume":"73","author":"Morotti","year":"2016","journal-title":"JAMA Neurol."},{"issue":"11","key":"10.1016\/j.thromres.2025.109321_bb0125","doi-asserted-by":"crossref","DOI":"10.1017\/S0007114515003694","article-title":"Acute effects of calcium supplements on blood pressure and blood coagulation: secondary analysis of a randomised controlled trial in post-menopausal women","volume":"114","author":"Bristow","year":"2015","journal-title":"Br. J. Nutr."},{"issue":"3","key":"10.1016\/j.thromres.2025.109321_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpath.2019.11.004","article-title":"Endothelial cell calcium signaling during barrier function and inflammation","volume":"190","author":"Dalal","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/S0171-2985(11)80266-4","article-title":"Modulation of adhesion molecule expression on endothelial cells by verapamil and other Ca++ channel blockers","volume":"191","author":"Hailer","year":"1994","journal-title":"Immunobiology"},{"issue":"3","key":"10.1016\/j.thromres.2025.109321_bb0140","article-title":"Ca2+ switches the effect of PS-containing membranes on Factor Xa from activating to inhibiting: implications for initiation of blood coagulation","volume":"462","author":"Koklic","year":"2014","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.thromres.2025.109321_bb0145","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.12066","article-title":"Lipopolysaccharide induces a fibrotic-like phenotype in endothelial cells","volume":"17","author":"Echeverr\u00eda","year":"2013","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"10.1016\/j.thromres.2025.109321_bb0150","article-title":"The expression of TRPM7 in serum of patients with sepsis, its influences on inflammatory factors and prognosis, and its diagnostic value","volume":"23","author":"Liu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.thromres.2025.109321_bb0155","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20200740","article-title":"LPS promotes the progression of sepsis by activation of lncRNA HULC\/miR-204-5p\/TRPM7 network in HUVECs","volume":"40","author":"Chen","year":"2020","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0160","doi-asserted-by":"crossref","DOI":"10.1002\/jcb.26233","article-title":"Salvianolic acid B protects against acute lung injury by decreasing TRPM6 and TRPM7 expressions in a rat model of sepsis","volume":"119","author":"Yang","year":"2018","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0165","article-title":"Disseminated intravascular coagulation phenotype is regulated by the TRPM7 channel during sepsis","volume":"56","author":"Jim\u00e9nez-Dinamarca","year":"2023","journal-title":"Biol. Res."},{"issue":"18","key":"10.1016\/j.thromres.2025.109321_bb0170","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2013-10-463646","article-title":"Thrombosis: tangled up in NETs","volume":"123","author":"Martinod","year":"2014","journal-title":"Blood"},{"issue":"9_suppl","key":"10.1016\/j.thromres.2025.109321_bb0175","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618806424","article-title":"Disseminated intravascular coagulation: an update on pathogenesis, diagnosis, and therapeutic strategies","volume":"24","author":"Papageorgiou","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0180","article-title":"Disseminated intravascular coagulation","volume":"2","author":"Gando","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"3","key":"10.1016\/j.thromres.2025.109321_bb0185","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000000719","article-title":"Evidence of netosis in septic shock-induced disseminated intravascular coagulation","volume":"47","author":"Delabranche","year":"2017","journal-title":"Shock"},{"issue":"4","key":"10.1016\/j.thromres.2025.109321_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2015.12.004","article-title":"DAMP and DIC: the role of extracellular DNA and DNA-binding proteins in the pathogenesis of DIC","volume":"30","author":"Liaw","year":"2016","journal-title":"Blood Rev."},{"issue":"6002","key":"10.1016\/j.thromres.2025.109321_bb0195","doi-asserted-by":"crossref","DOI":"10.1126\/science.1195491","article-title":"Intravascular danger signals guide neutrophils to sites of sterile inflammation","volume":"330","author":"McDonald","year":"2010","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0200","doi-asserted-by":"crossref","DOI":"10.1111\/j.1538-7836.2006.02255.x","article-title":"High-mobility group box 1 protein promotes development of microvascular thrombosis in rats","volume":"5","author":"Ito","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"7","key":"10.1016\/j.thromres.2025.109321_bb0205","doi-asserted-by":"crossref","DOI":"10.1172\/JCI46129","article-title":"P2X7 receptor signaling contributes to tissue factor\u2013dependent thrombosis in mice","volume":"121","author":"Furlan-Freguia","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.thromres.2025.109321_bb0210","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0215","doi-asserted-by":"crossref","DOI":"10.1186\/s40560-023-00672-5","article-title":"The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation","volume":"11","author":"Iba","year":"2023","journal-title":"J. Intensive Care"},{"issue":"4","key":"10.1016\/j.thromres.2025.109321_bb0220","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000005067","article-title":"Biomarker evidence of the Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) in Chronic Critical Illness (CCI) after surgical sepsis","volume":"274","author":"Darden","year":"2021","journal-title":"Ann. Surg."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0225","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glab080","article-title":"Older adults demonstrate biomarker evidence of the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS) after sepsis","volume":"77","author":"Mankowski","year":"2022","journal-title":"J. Gerontol. Ser. A"},{"issue":"8","key":"10.1016\/j.thromres.2025.109321_bb0230","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.8686","article-title":"Long-term host immune response trajectories among hospitalized patients with sepsis","volume":"2","author":"Yende","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"4","key":"10.1016\/j.thromres.2025.109321_bb0235","doi-asserted-by":"crossref","DOI":"10.1097\/SLA.0000000000001783","article-title":"Human myeloid-derived suppressor cells are associated with chronic immune suppression after severe sepsis\/septic shock","volume":"265","author":"Mathias","year":"2017","journal-title":"Ann. Surg."},{"issue":"3","key":"10.1016\/j.thromres.2025.109321_bb0240","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000000981","article-title":"Evidence for persistent immune suppression in patients who develop chronic critical illness after sepsis","volume":"49","author":"Stortz","year":"2018","journal-title":"Shock"},{"issue":"5","key":"10.1016\/j.thromres.2025.109321_bb0245","doi-asserted-by":"crossref","DOI":"10.1097\/TA.0000000000004087","article-title":"The persistent inflammation, immunosuppression, and catabolism syndrome 10 years later","volume":"95","author":"Efron","year":"2023","journal-title":"J. Traum. Acute Care Surg."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0250","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-101320-125839","article-title":"Immune mechanisms in inflammatory anemia","volume":"41","author":"Canny","year":"2023","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0255","doi-asserted-by":"crossref","DOI":"10.1097\/MOH.0000000000000395","article-title":"Dysregulated myelopoiesis and hematopoietic function following acute physiologic insult","volume":"25","author":"Loftus","year":"2018","journal-title":"Curr. Opin. Hematol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109321_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcna.2016.09.005","article-title":"Anemia of inflammation: a review","volume":"101","author":"Fraenkel","year":"2017","journal-title":"Med. Clin. North Am."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0265","doi-asserted-by":"crossref","DOI":"10.1007\/s13239-020-00486-8","article-title":"Anisodamine hydrobromide protects glycocalyx and against the lipopolysaccharide-induced increases in microvascular endothelial layer permeability and nitric oxide production","volume":"12","author":"Du","year":"2021","journal-title":"Cardiovasc. Eng. Technol."},{"issue":"9","key":"10.1016\/j.thromres.2025.109321_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.tcb.2009.06.002","article-title":"Molecular mechanisms involved in inflammasome activation","volume":"19","author":"Bryant","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.thromres.2025.109321_bb0275","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.thromres.2025.109321_bb0280","first-page":"29","article-title":"The inflammasome NLRs in immunity, inflammation, and associated diseases","author":"Davis","year":"2011","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.thromres.2025.109321_bb0285","doi-asserted-by":"crossref","DOI":"10.1038\/ni.1703","article-title":"The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis","volume":"10","author":"Franchi","year":"2009","journal-title":"Nat. Immunol."},{"issue":"28","key":"10.1016\/j.thromres.2025.109321_bb0290","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1117765109","article-title":"Critical role for calcium mobilization in activation of the NLRP3 inflammasome","volume":"109","author":"Murakami","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0295","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-019-2628-x","article-title":"Myeloid-derived suppressor cell function and epigenetic expression evolves over time after surgical sepsis","volume":"23","author":"Hollen","year":"2019","journal-title":"Crit. Care"},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamcollsurg.2019.04.014","article-title":"Persistently elevated glucagon-like peptide-1 levels among critically ill surgical patients after sepsis and development of chronic critical illness and dismal long-term outcomes","volume":"229","author":"Brakenridge","year":"2019","journal-title":"J. Am. Coll. Surg."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0305","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-0788-x","article-title":"Advanced age is associated with worsened outcomes and a unique genomic response in severely injured patients with hemorrhagic shock","volume":"19","author":"Vanzant","year":"2015","journal-title":"Crit. Care"},{"issue":"3","key":"10.1016\/j.thromres.2025.109321_bb0310","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12320","article-title":"Global analyses revealed age-related alterations in innate immune responses after stimulation of pathogen recognition receptors","volume":"14","author":"Metcalf","year":"2015","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0315","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"7","key":"10.1016\/j.thromres.2025.109321_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2017.03.010","article-title":"GLP-1 levels predict mortality in patients with critical illness as well as end-stage renal disease","volume":"130","author":"Lebherz","year":"2017","journal-title":"Am. J. Med."},{"key":"10.1016\/j.thromres.2025.109321_bb0325","first-page":"9","article-title":"Hypercatabolism and anti-catabolic therapies in the persistent inflammation, immunosuppression, and catabolism syndrome","author":"Zhang","year":"2022","journal-title":"Front. Nutr."},{"key":"10.1016\/j.thromres.2025.109321_bb0330","series-title":"Dysregulated Immune Response and Organ Dysfunction: The Muscles. Lessons From the ICU","author":"Flower","year":"2023"},{"issue":"6","key":"10.1016\/j.thromres.2025.109321_bb0335","doi-asserted-by":"crossref","DOI":"10.1002\/jcsm.12620","article-title":"Muscular weakness and muscle wasting in the critically ill","volume":"11","author":"Schefold","year":"2020","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.jss.2006.04.028","article-title":"IGF-1 protects intestinal epithelial cells from oxidative stress-induced apoptosis","volume":"136","author":"Baregamian","year":"2006","journal-title":"J. Surg. Res."},{"issue":"2","key":"10.1016\/j.thromres.2025.109321_bb0345","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2009020213","article-title":"Reassessment of albumin as a nutritional marker in kidney disease","volume":"21","author":"Friedman","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"issue":"2","key":"10.1016\/j.thromres.2025.109321_bb0350","doi-asserted-by":"crossref","DOI":"10.1007\/s10753-011-9337-1","article-title":"Time-dependent alterations of VEGF and its signaling molecules in acute lung injury in a rat model of Sepsis","volume":"35","author":"Jesmin","year":"2011","journal-title":"Inflammation"},{"issue":"6","key":"10.1016\/j.thromres.2025.109321_bb0355","doi-asserted-by":"crossref","DOI":"10.1515\/CCLM.1998.064","article-title":"Strongly enhanced serum levels of Vascular Endothelial Growth Factor (VEGF) after poly-trauma and burn","volume":"36","author":"Grad","year":"1998","journal-title":"Clin. Chem. Lab. Med. (CCLM)"},{"issue":"6","key":"10.1016\/j.thromres.2025.109321_bb0360","doi-asserted-by":"crossref","DOI":"10.1097\/SHK.0000000000001675","article-title":"Lymphocyte immunosuppression and dysfunction contributing to Persistent Inflammation, Immunosuppression, and Catabolism Syndrome (PICS)","volume":"55","author":"Bergmann","year":"2021","journal-title":"Shock"},{"issue":"01","key":"10.1016\/j.thromres.2025.109321_bb0365","article-title":"Recombinant human soluble thrombomodulin in sepsis-induced coagulopathy: an updated systematic review and Meta-analysis","volume":"119","author":"Yamakawa","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2025.109321_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12113822","article-title":"Effects of antithrombin on persistent inflammation, immunosuppression, and catabolism syndrome among patients with Sepsis-induced disseminated intravascular coagulation","volume":"12","author":"Kanda","year":"2023","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.thromres.2025.109321_bb0375","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12643","article-title":"Antithrombin and mortality in severe pneumonia patients with sepsis-associated disseminated intravascular coagulation: an observational nationwide study","volume":"12","author":"Tagami","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2025.109321_bb0380","doi-asserted-by":"crossref","DOI":"10.1111\/jth.13230","article-title":"Efficacy and safety of anticoagulant therapy in three specific populations with sepsis: a meta-analysis of randomized controlled trials","volume":"14","author":"Umemura","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0385","doi-asserted-by":"crossref","DOI":"10.1111\/j.1538-7836.2005.01697.x","article-title":"Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation","volume":"4","author":"Kienast","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2025.109321_bb0390","doi-asserted-by":"crossref","DOI":"10.1177\/1076029618757346","article-title":"Optimal antithrombin activity threshold for initiating antithrombin supplementation in patients with sepsis-induced disseminated intravascular coagulation: a multicenter retrospective observational study","author":"Hayakawa","year":"2018","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"09","key":"10.1016\/j.thromres.2025.109321_bb0395","article-title":"Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis","volume":"114","author":"Tagami","year":"2015","journal-title":"Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0400","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2009.08.017","article-title":"Expert consensus for the treatment of disseminated intravascular coagulation in Japan","volume":"125","author":"Wada","year":"2010","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0405","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation","volume":"145","author":"Levi","year":"2009","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2025.109321_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2011.08.028","article-title":"Diagnosis and treatment of disseminated intravascular coagulation: guidelines of the Italian Society for Haemostasis and Thrombosis (SISET)","volume":"129","author":"Di Nisio","year":"2012","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2025.109321_bb0415","article-title":"Recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy (SCARLET): an updated meta-analysis","volume":"23","author":"Yamakawa","year":"2019","journal-title":"Crit. Care (Lond., Engl.)"},{"issue":"4","key":"10.1016\/j.thromres.2025.109321_bb0420","doi-asserted-by":"crossref","DOI":"10.1111\/jth.12155","article-title":"Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines","volume":"11","author":"Wada","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2025.109321_bb0425","first-page":"296","article-title":"Clinical evaluation of new therapeutic concepts in septic shock","volume":"27","author":"Martinez","year":"1966","journal-title":"Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.thromres.2025.109321_bb0430","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"10","key":"10.1016\/j.thromres.2025.109321_bb0435","doi-asserted-by":"crossref","DOI":"10.1111\/jth.15808","article-title":"ISTH guidelines for antithrombotic treatment in COVID-19","volume":"20","author":"Schulman","year":"2022","journal-title":"J. Thrombos. Haemostas."},{"key":"10.1016\/j.thromres.2025.109321_bb0440","first-page":"10","article-title":"Low-molecular-weight heparin therapy reduces 28-day mortality in patients with sepsis-3 by improving inflammation and coagulopathy","author":"Zhang","year":"2023","journal-title":"Front. Med."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384825000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T12:58:35Z","timestamp":1747400315000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384825000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":88,"alternative-id":["S0049384825000702"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109321","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disseminated Intravascular Coagulopathy and Persistent Inflammation, Immunosuppression, and Catabolism Syndrome: Pathophysiology, shared pathways, and clinical implications","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2025.109321","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109321"}}